Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week The Long Read Changes at the Patent Trial and Appeal Board have transformed the inter partes review environment for companies in the life sciences sector. Kramer Levin’s Hannah Lee and Irena Royzman provide crucial strategic insights that can help both rights holders and petitioners prevail. Read more here MONDAY 26 July Patent sales made by Virginia-based R&D outfit Ofinno to the likes of Xiaomi, Honda and Samsung…